Dr. Mopelola Adetola Adeyemo, MD

Dr. Adeyemo practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Adeyemo's NPI, 1457731572, was assigned on June 3, 2015. Dr. Adeyemo graduated from College of Human Medicine - Grand Rapids in 2015. Dr. Adeyemo holds California license A150028.

Dr. Adeyemo's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Adeyemo's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Adeyemo's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adeyemo practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Adeyemo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Adeyemo is board certified in internal medicine by the American Board of Internal Medicine. Dr. Adeyemo is licensed in California.

Dmand AI lists chronic diabetes, chronic hypertension, chronic indigestion, cirrhosis of the liver, gastroduodenitis, gastroenteritis, high cholesterol and obesity among the conditions Dr. Adeyemo treats.

CMS data shows 148 Medicare services from Dr. Adeyemo across 3 procedure codes in 2024, all of them office visits, for 114 Medicare patients. Medicare paid $15,314 for them.

CMS counts 114 Medicare patients who saw Dr. Adeyemo in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adeyemo's median patient age at 54, with 69% women.

In 2024, Dr. Adeyemo wrote 129 Medicare Part D claims for 39 patients. 61% of them were for generic drugs. CMS names the drug for 112 of them, across 3 drugs with 11 or more claims each, at $70,677 in total drug cost. In 2023, CMS named 73 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Adeyemo for performance year 2024, reported as part of a group. CMS lists Dr. Adeyemo as offering telehealth.

Dmand AI links 6 papers to Dr. Adeyemo, published from 2011 to 2025. 2015 was the busiest year, with 2. Dr. Adeyemo's most frequent co-authors are Charles Thomas Chaya, MD, Andrew Q. Giap, MD and Agathon A. Girgis, MD.

CMS Open Payments shows 11 general payments to Dr. Adeyemo from 5 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $359.

Dr. Adeyemo graduated from College of Human Medicine - Grand Rapids in 2015.

Dr. Adeyemo is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.